IDXX

2024Q4BMO

IDEXX Laboratories Inc primary · HEALTHCARE · DIAGNOSTICS & RESEARCH

Report 2025-02-03 · Fiscal end 2024-12-31 · Features as of 2025-01-31

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS2.40
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move4.1%
IV front—
P/C full—
P/C front—
Features as of2025-01-31

Run-up

Close—
Ret 5d-3.1%
Ret 10d-1.5%
Ret 20d+2.1%
Ret 30d-2.0%

Post-Earnings Data

Results & reaction

Print

Actual EPS
2.62Beat
Estimated EPS2.40
Actual revenue
954.3M
Surprise %+9.2%
Beat / missBeat
Beat streak 44
Beat streak 88

Reaction

1-day stock reaction+0.9%
Implied vs actual

Implied 4.1%Actual 10.2%

Gap reaction+10.2%
Day result+11.1%
Next-day upYes
Realized / IV2.50×

Post tape

Post 5d-0.9%
Post 10d-4.3%
Post volume1.5M
Vol ×10d1.74×
Vol ×20d2.17×
Post range6.4%